SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Infinity Pharmaceuticals
INFI 0.0160-4.8%Sep 29 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (78)8/31/2006 11:05:46 PM
From: Mike McFarland   of 210
 
(had to look a couple things up)

Pharmacophore - A pharmacophore is the
ensemble of steric and electronic features that is necessary
to ensure the optimal supramolecular interactions with a
specific biological target structure and to trigger (or to
block) its biological response. A pharmacophore does not
represent a real molecule or a real association of
functional groups, but a purely abstract concept that
accounts for the common molecular interaction capacities of
a group of compounds towards their target structure.

Privileged structure - Substructural
feature which confers desirable (often drug- like)
properties on compounds containing that feature. Often
consists of a semi- rigid scaffold which is able to present
multiple hydrophobic residues without undergoing hydrophobic
collapse.

bioscreening.net
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext